Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly A Teicher

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Protein kinase C as a therapeutic targetBeverly A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Molecular targets and cancer therapeutics: discovery, development and clinical validationBeverly A. Teicher
Current Opinion in Oncology|July 16, 2014
Antibody drug conjugatesBeverly A Teicher
Molecular Cancer Therapeutics|November 4, 2021
Twentieth Anniversary of <i>Molecular Cancer Therapeutics</i>: A Vision for the FutureBeverly A Teicher
Biochemical Pharmacology|March 6, 2012
Searching for molecular targets in sarcomaBeverly A Teicher
Current Opinion in Pharmacology|June 16, 2010
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugsBeverly A Teicher
Advances in Experimental Medicine and Biology|April 6, 2006
Hypoxia, tumor endothelium, and targets for therapyBeverly A Teicher
Biochemical Pharmacology|May 12, 2009
Acute and chronic in vivo therapeutic resistanceBeverly A Teicher
Molecular Cancer Therapeutics|March 3, 2019
A Vision from the New Editor-in-ChiefBeverly A Teicher
Oncotarget|March 9, 2019
CD248: A therapeutic target in cancer and fibrotic diseasesBeverly A Teicher
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Protein kinase C as a therapeutic targetBeverly A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Molecular targets and cancer therapeutics: discovery, development and clinical validationBeverly A. Teicher
Current Opinion in Oncology|July 16, 2014
Antibody drug conjugatesBeverly A Teicher
Molecular Cancer Therapeutics|November 4, 2021
Twentieth Anniversary of <i>Molecular Cancer Therapeutics</i>: A Vision for the FutureBeverly A Teicher
Biochemical Pharmacology|March 6, 2012
Searching for molecular targets in sarcomaBeverly A Teicher
Current Opinion in Pharmacology|June 16, 2010
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugsBeverly A Teicher
Advances in Experimental Medicine and Biology|April 6, 2006
Hypoxia, tumor endothelium, and targets for therapyBeverly A Teicher
Biochemical Pharmacology|May 12, 2009
Acute and chronic in vivo therapeutic resistanceBeverly A Teicher
Molecular Cancer Therapeutics|March 3, 2019
A Vision from the New Editor-in-ChiefBeverly A Teicher
Oncotarget|March 9, 2019
CD248: A therapeutic target in cancer and fibrotic diseasesBeverly A Teicher
Pageof 16